PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8(+) T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Tumor-reactive T cell exhaustion prevents the success of immune therapies. Pegilodecakin activates intratumoral CD8(+) T cells in mice and induces objective tumor responses in patients. Here we report that pegilodecakin induces hallmarks of CD8(+) T cell immunity in cancer patients, including elevat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Cell
Main Authors: Naing, Aung, Infante, Jeffrey R., Papadopoulos, Kyriakos P., Chan, Ivan H., Shen, Cong, Ratti, Navneet P., Rojo, Bianca, Autio, Karen A., Wong, Deborah J., Patel, Manish R., Ott, Patrick A., Falchook, Gerald S., Pant, Shubham, Hung, Annie, Pekarek, Kara L., Wu, Victoria, Adamow, Matthew, McCauley, Scott, Mumm, John B., Wong, Phillip, Vlasselaer, Peter Van, Leveque, Joseph, Tannir, Nizar M., Oft, Martin
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8098754/
https://ncbi.nlm.nih.gov/pubmed/30423297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2018.10.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares